Leukemia acute myeloid - AML

Clinical trials for Leukemia acute myeloid - AML explained in plain language.

Never miss a new study

Get alerted when new Leukemia acute myeloid - AML trials appear

Sign up with your email to follow new studies for Leukemia acute myeloid - AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

New pill shows promise for aggressive leukemia

Disease control Completed

This study tested a new drug called gilteritinib against standard chemotherapy in 371 adults with a type of acute myeloid leukemia (AML) that has a specific genetic change (FLT3 mutation) and has either come back or not responded to initial treatment. The goal was to see if gilte…

Matched conditions: LEUKEMIA ACUTE MYELOID - AML

Phase 3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

Leukemia acute myeloid - AML

Get alerted when new Leukemia acute myeloid - AML trials appear

New pill shows promise for aggressive leukemia